What Cigna Group (CI) Said on Its Q3 Earnings Call
Cigna Group (NYSE:CI) raised its full-year adjusted earnings outlook after reporting $73.8 billion in adjusted revenue and $2 ...
Model output · Signal date 2026-11-06
Cigna Group (CI) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Rating · 90D
Unlock rating and forecasts
90-day forecast
Sign up free to reveal
30-day forecast
Alpha
Rank in coverage
of 5150 stocks scored
Rank correlation · 90D
25.0%
Spearman, 357 dates
Market Cap
$77.58B
large-cap · #3 of 10 peers
Summary
Cigna Group (CI) stock forecast summary
Our AI scores Cigna Group every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Cigna Group is a large-cap company with a market capitalization of $77.58B. It ranks number 3 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast.
For CI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 25.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 29.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CI included.
Price
CI price chart and AI forecast
Cross-section · 2026-11-06
How CI ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2026-09-30
Cigna Group (CI) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
Valuation & Market
| Metric | CI | Rank |
|---|---|---|
| Market Cap | $77.58B | 3/10 |
| P/E Ratio | 12.96x | 6/7 |
| P/B Ratio | 1.79x | 9/10 |
| Dividend Yield | 2.10% | – |
| EPS | $22.66 | – |
| Book Value/Share | $164.18 | – |
| Revenue/Share | $1083.55 | – |
Profitability & Margins
| Metric | CI | Rank |
|---|---|---|
| ROE | 13.8% | 3/7 |
| ROA | 3.8% | 4/7 |
| ROIC | 9.6% | 3/10 |
| Gross Margin | 20.6% | 4/6 |
| Operating Margin | 3.4% | 3/10 |
| Net Margin | 2.1% | 4/7 |
| EBT Margin | 3.0% | 4/10 |
| Tax Rate | 20.6% | – |
Financial Health
| Metric | CI | Rank |
|---|---|---|
| Current Ratio | 0.84x | 9/10 |
| Quick Ratio | 0.74x | – |
| D/E Ratio | 2.63x | 4/10 |
| Financial Leverage | 3.63x | 4/10 |
| Interest Coverage | 6.7x | 3/6 |
| Working Capital | -$8.80B | 9/10 |
Cash Flow
| Metric | CI | Rank |
|---|---|---|
| Operating Cash Flow | $9.43B | 2/10 |
| OCF Growth YoY | 8.8% | 7/8 |
Operational Efficiency
| Metric | CI | Rank |
|---|---|---|
| Asset Turnover | 1.82x | 6/10 |
| Receivables Turnover | 9.1x | 6/6 |
| Inventory Turnover | 40.9x | – |
| Fixed Assets Turnover | 76.6x | 5/10 |
| Days Sales Outstanding | 40 days | 1/6 |
| Days Inventory | 9 days | – |
| Payables Period | 16 days | – |
| Cash Conversion Cycle | 33 days | – |
Income Statement
| Metric | CI | Rank |
|---|---|---|
| Total Revenue | $286.32B | 2/10 |
| Operating Income | $9.78B | 2/10 |
| Net Income | $5.99B | 2/7 |
| SG&A Expense | $14.41B | 4/8 |
| Cost of Goods Sold | $227.19B | 1/6 |
Dividend & Shareholder Information
| Metric | CI | Rank |
|---|---|---|
| Dividends Per Share | $6.18 | – |
| Payout Ratio | 27.3% | – |
| Shares Outstanding | 264M | – |
| Net Income Growth | -2.5% | 2/5 |
| EPS Growth | 0.5% | 1/5 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $47.23B | 30.0% of assets |
| Cash & Short-term Investments | $6.19B | 3.9% of assets |
| Accounts Receivable | $31.49B | 20.0% of assets |
| Inventory | $5.55B | 3.5% of assets |
| Total Liabilities | $113.92B | 72.3% of assets |
| Short-term Debt | $45.93B | 29.1% of assets |
Quarterly Financial Reports
CI quarterly financials and insider trading
Industry Peers · Hospital & Medical Service Plans
Cigna Group (CI) industry peers
Companies classified under the same SEC industry code as Cigna Group (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CI Cigna Group | $77.58B | |
| UNH Unitedhealth Group Inc | $353.79B | |
| ELV Elevance Health, Inc. | $93.34B | |
| HUM Humana Inc | $52.17B | |
| CNC Centene Corp | $34.53B | |
| MOH Molina Healthcare, Inc. | $11.31B | |
| OSCR Oscar Health, Inc. | $9.46B | |
| CLOV Clover Health Investments, Corp. /De | $2.56B | |
| TRUP Trupanion, Inc. | $1.61B | |
| ALHC Alignment Healthcare, Inc. | $1.54B |
Where CI sits on the market map
Finance · Hospital & Medical Service Plans
News
Cigna Group (CI) stock news
Cigna Profits Hit $1.4 Billion As Health Insurer Controls Costs
The Cigna Group reported third quarter net income of $1.4 billion as the company maintains a handle on its medical costs, ...
Cigna Group lifts outlook as revenue climbs
The healthcare company reported a third-quarter profit of $1.44 billion, or $5.47 a share, compared with $1.87 billion, or $6 ...
FAQ
Cigna Group (CI) stock forecast FAQ
What is the Cigna Group (CI) stock forecast?
Our AI scores Cigna Group every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Cigna Group stock predictions?
For CI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 25.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 29.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cigna Group forecasts updated?
Cigna Group forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Cigna Group's industry peers?
10 issuers in our coverage, CI included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.